Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   long qt syndrome
  

Disease ID 329
Disease long qt syndrome
Definition
A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Synonym
long q t syndrome
long q-t syndrome
long q-t syndrome (disorder)
long qt syndrome (disorder)
long qt syndrome [disease/finding]
long qt syndrome, nos
lqt
prolonged q-t interval syndrome
prolonged q-t interval syndrome, nos
ventricular arrhythmia associated with long qt syndrome
DOID
ICD10
UMLS
C0023976
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:15)
C0004245  |  atrioventricular block  |  3
C0038644  |  sudden infant death  |  1
C0018021  |  goiter  |  1
C0037315  |  sleep apnea  |  1
C0020598  |  hypoglycemia  |  1
C0004096  |  asthma  |  1
C1960469  |  left ventricular noncompaction  |  1
C0004245  |  av block  |  1
C1631597  |  catecholaminergic polymorphic ventricular tachycardia  |  1
C1565489  |  renal insufficiency  |  1
C0001623  |  adrenal insufficiency  |  1
C0043202  |  wolff-parkinson-white syndrome  |  1
C0038644  |  sudden infant death syndrome  |  1
C0520679  |  obstructive sleep apnea  |  1
C0024623  |  gastric cancer  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:18)
3784  |  KCNQ1  |  CLINVAR;CTD_human;UniProtKB-KW;GHR
775  |  CACNA1C  |  CLINVAR;UniProtKB-KW
859  |  CAV3  |  CLINVAR;UniProtKB-KW
5443  |  POMC  |  CTD_human
5728  |  PTEN  |  CTD_human
23171  |  GPD1L  |  CLINVAR
3757  |  KCNH2  |  CLINVAR;CTD_human;UniProtKB-KW;GHR
6331  |  SCN5A  |  CLINVAR;CTD_human;UniProtKB-KW;GHR
1832  |  DSP  |  CLINVAR
6330  |  SCN4B  |  UniProtKB-KW
6262  |  RYR2  |  CLINVAR
6640  |  SNTA1  |  CLINVAR;UniProtKB-KW
3759  |  KCNJ2  |  CLINVAR;UniProtKB-KW;GHR
3762  |  KCNJ5  |  UniProtKB-KW
3753  |  KCNE1  |  CLINVAR;CTD_human;UniProtKB-KW;GHR
9992  |  KCNE2  |  CLINVAR;CTD_human;UniProtKB-KW;GHR
287  |  ANK2  |  CLINVAR;UniProtKB-KW;GHR
10142  |  AKAP9  |  CLINVAR;UniProtKB-KW
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:23)
1636  |  ACE  |  CIPHER
152  |  ADRA2C  |  CIPHER
153  |  ADRB1  |  CIPHER
154  |  ADRB2  |  CIPHER
287  |  ANK2  |  CIPHER
717  |  C2  |  CIPHER
3077  |  HFE  |  CIPHER
3162  |  HMOX1  |  CIPHER
3753  |  KCNE1  |  CIPHER;CTD_human
9992  |  KCNE2  |  CIPHER;CTD_human
10008  |  KCNE3  |  CIPHER
3757  |  KCNH2  |  CIPHER;CTD_human
3759  |  KCNJ2  |  CIPHER
3784  |  KCNQ1  |  CIPHER;CTD_human
50488  |  MINK1  |  CIPHER
4318  |  MMP9  |  CIPHER
9722  |  NOS1AP  |  CIPHER
6262  |  RYR2  |  CIPHER
6331  |  SCN5A  |  CIPHER;CTD_human
7018  |  TF  |  CIPHER
7077  |  TIMP2  |  CIPHER
5728  |  PTEN  |  CTD_human
5443  |  POMC  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:111)
88  |  ACTN2  |  1.197  |  DISEASES
98  |  ACYP2  |  1.49  |  DISEASES
152  |  ADRA2C  |  1.286  |  DISEASES
153  |  ADRB1  |  2.378  |  DISEASES
8165  |  AKAP1  |  2.805  |  DISEASES
10142  |  AKAP9  |  4.89  |  DISEASES
208  |  AKT2  |  1.178  |  DISEASES
287  |  ANK2  |  5.548  |  DISEASES
395  |  ARHGAP6  |  1.611  |  DISEASES
22926  |  ATF6  |  1.259  |  DISEASES
481  |  ATP1B1  |  1.319  |  DISEASES
493  |  ATP2B4  |  2.902  |  DISEASES
9532  |  BAG2  |  1.247  |  DISEASES
779  |  CACNA1S  |  1.509  |  DISEASES
801  |  CALM1  |  3.684  |  DISEASES
857  |  CAV1  |  2.243  |  DISEASES
859  |  CAV3  |  4.117  |  DISEASES
23607  |  CD2AP  |  4.096  |  DISEASES
1180  |  CLCN1  |  1.55  |  DISEASES
1183  |  CLCN4  |  1.265  |  DISEASES
23019  |  CNOT1  |  1.196  |  DISEASES
1565  |  CYP2D6  |  1.093  |  DISEASES
1576  |  CYP3A4  |  1.278  |  DISEASES
9681  |  DEPDC5  |  1  |  DISEASES
3301  |  DNAJA1  |  1.775  |  DISEASES
54788  |  DNAJB12  |  2.016  |  DISEASES
79982  |  DNAJB14  |  3.199  |  DISEASES
1804  |  DPP6  |  1.824  |  DISEASES
2274  |  FHL2  |  1.493  |  DISEASES
4303  |  FOXO4  |  1.647  |  DISEASES
2520  |  GAST  |  1.86  |  DISEASES
2689  |  GH2  |  1.621  |  DISEASES
64785  |  GINS3  |  1.793  |  DISEASES
2764  |  GMFB  |  1.819  |  DISEASES
2801  |  GOLGA2  |  1.187  |  DISEASES
56261  |  GPCPD1  |  1.305  |  DISEASES
2992  |  GYG1  |  1.348  |  DISEASES
3009  |  HIST1H1B  |  1.163  |  DISEASES
3269  |  HRH1  |  1.719  |  DISEASES
3320  |  HSP90AA1  |  1.963  |  DISEASES
10265  |  IRX5  |  1.5  |  DISEASES
3736  |  KCNA1  |  2.492  |  DISEASES
3744  |  KCNA10  |  3.026  |  DISEASES
3738  |  KCNA3  |  1.116  |  DISEASES
3739  |  KCNA4  |  3.663  |  DISEASES
7881  |  KCNAB1  |  1.5  |  DISEASES
3745  |  KCNB1  |  3.721  |  DISEASES
9312  |  KCNB2  |  2.701  |  DISEASES
3751  |  KCND2  |  3.711  |  DISEASES
3753  |  KCNE1  |  7.587  |  DISEASES
3755  |  KCNG1  |  2.169  |  DISEASES
81033  |  KCNH6  |  2.938  |  DISEASES
30819  |  KCNIP2  |  3.299  |  DISEASES
3758  |  KCNJ1  |  1.13  |  DISEASES
3767  |  KCNJ11  |  1.179  |  DISEASES
3768  |  KCNJ12  |  3.243  |  DISEASES
3772  |  KCNJ15  |  1.694  |  DISEASES
3762  |  KCNJ5  |  3.235  |  DISEASES
3775  |  KCNK1  |  2.308  |  DISEASES
3785  |  KCNQ2  |  3.511  |  DISEASES
3786  |  KCNQ3  |  3.682  |  DISEASES
56479  |  KCNQ5  |  3.479  |  DISEASES
284252  |  KCTD1  |  1.038  |  DISEASES
378938  |  MALAT1  |  1.766  |  DISEASES
8972  |  MGAM  |  1.294  |  DISEASES
440823  |  MIAT  |  1.735  |  DISEASES
50488  |  MINK1  |  2.77  |  DISEASES
4357  |  MPST  |  1.133  |  DISEASES
136319  |  MTPN  |  1.389  |  DISEASES
4625  |  MYH7  |  2.22  |  DISEASES
85366  |  MYLK2  |  2.749  |  DISEASES
89796  |  NAV1  |  3.725  |  DISEASES
65009  |  NDRG4  |  1.973  |  DISEASES
10529  |  NEBL  |  1.595  |  DISEASES
4734  |  NEDD4  |  1.511  |  DISEASES
23327  |  NEDD4L  |  3.079  |  DISEASES
91624  |  NEXN  |  1.179  |  DISEASES
23114  |  NFASC  |  2.288  |  DISEASES
9722  |  NOS1AP  |  3.91  |  DISEASES
594857  |  NPS  |  1.199  |  DISEASES
55361  |  PI4K2A  |  2.94  |  DISEASES
5293  |  PIK3CD  |  3.403  |  DISEASES
5787  |  PTPRB  |  2.44  |  DISEASES
5803  |  PTPRZ1  |  2.185  |  DISEASES
284119  |  PTRF  |  1.699  |  DISEASES
5867  |  RAB4A  |  1.651  |  DISEASES
25780  |  RASGRP3  |  1.387  |  DISEASES
196475  |  RMST  |  1.675  |  DISEASES
388591  |  RNF207  |  2.474  |  DISEASES
6262  |  RYR2  |  4.787  |  DISEASES
6324  |  SCN1B  |  2.493  |  DISEASES
6329  |  SCN4A  |  2.837  |  DISEASES
6330  |  SCN4B  |  3.931  |  DISEASES
6331  |  SCN5A  |  7.889  |  DISEASES
6335  |  SCN9A  |  1.188  |  DISEASES
6446  |  SGK1  |  2.77  |  DISEASES
6512  |  SLC1A7  |  1.172  |  DISEASES
6546  |  SLC8A1  |  2.115  |  DISEASES
26768  |  SNORA73B  |  1.573  |  DISEASES
23673  |  STX12  |  2.366  |  DISEASES
57057  |  TBX20  |  1.003  |  DISEASES
7033  |  TFF3  |  1.431  |  DISEASES
7171  |  TPM4  |  1.038  |  DISEASES
7179  |  TPTE  |  3.196  |  DISEASES
7327  |  UBE2G2  |  2.465  |  DISEASES
7453  |  WARS  |  3.428  |  DISEASES
65267  |  WNK3  |  1.638  |  DISEASES
7485  |  WRB  |  1.016  |  DISEASES
7709  |  ZBTB17  |  2.368  |  DISEASES
151126  |  ZNF385B  |  1.944  |  DISEASES
100128252  |  ZNF667-AS1  |  1.907  |  DISEASES
Locus(Waiting for update.)
Disease ID 329
Disease long qt syndrome
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:29)
HP:0001664  |  Torsade de pointes  |  14
HP:0011675  |  Arrhythmias  |  14
HP:0004756  |  Ventricular tachycardia  |  10
HP:0001649  |  Tachycardia  |  10
HP:0001663  |  Ventricular fibrillation  |  5
HP:0001695  |  Cardiac arrest  |  5
HP:0004308  |  Ventricular arrhythmia  |  5
HP:0001645  |  Sudden cardiac death  |  3
HP:0001279  |  Syncope  |  2
HP:0001678  |  Atrioventricular block  |  2
HP:0001943  |  Hypoglycemia  |  2
HP:0002045  |  Abnormally low body temperature  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0000365  |  Hearing impairment  |  1
HP:0001716  |  Wolff-Parkinson-White syndrome  |  1
HP:0002099  |  Asthma  |  1
HP:0005110  |  Atrial fibrillation  |  1
HP:0000846  |  Hypoadrenalism  |  1
HP:0000853  |  Goitre  |  1
HP:0012266  |  T-wave alternans  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0002104  |  Absence of spontaneous respiration  |  1
HP:0004755  |  Supraventricular tachycardia  |  1
HP:0007185  |  Loss of consciousness  |  1
HP:0030682  |  Left ventricular noncompaction  |  1
HP:0002870  |  Obstructive sleep apnea  |  1
HP:0001636  |  Tetrology of fallot  |  1
HP:0002353  |  Abnormal EEG  |  1
HP:0010535  |  Sleep apnea  |  1
Disease ID 329
Disease long qt syndrome
Manually Symptom
UMLS  | Name(Total Manually Symptoms:7)
C2717907  |  isolated non-compaction of the ventricular myocardium
C2712322  |  tachycardia
C2108112  |  ventricular fibrillation
C0751535  |  cardiac syncope
C0750197  |  sustained ventricular tachycardia
C0700323  |  neuromuscular blockade
C0039070  |  syncope
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:4)
C0039231  |  tachycardia  |  10
C0042510  |  ventricular fibrillation  |  5
C0039070  |  syncope  |  2
C0750197  |  sustained ventricular tachycardia  |  1
Manually Genotype(Total Manually Genotypes:1)
Gene Mutation DOI Article Title
SCN5ANM_198056.2:c.3250G>A, NP_932173.1:p.Gly1084Serdoi:10.1038/gim.2015.26Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:191)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs104893714235419536331SCN5Aumls:C0023976BeFreeHEK-293 cells expressing SCN5A and LQT9 mutation Cav3-F97C resulted in a 2-fold increase in late INa compared to Cav3-WT.0.3349785012013CAV3;SSUH238745701TG
rs104893714235419532042EPHA3umls:C0023976BeFreeHEK-293 cells expressing SCN5A and LQT9 mutation Cav3-F97C resulted in a 2-fold increase in late INa compared to Cav3-WT.0.0002714422013CAV3;SSUH238745701TG
rs120074177NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112570682GA,C
rs120074179NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572089GA,C,T
rs120074179128207043784KCNQ1umls:C0023976BeFreeThe second mutation, V254M in KCNQ1, co-segregated with higher QT intervals and symptoms in other family members, and was previously reported in another LQTS family.0.4165108372003KCNQ1112572089GA,C,T
rs120074184193487853753KCNE1umls:C0023976BeFreeG314S, co-expressed with WT KCNQ1 and KCNE1, suppressed I(ks) currents in a dominant-negative manner, which is consistent with long QT syndrome in the members of the Chinese family carrying G314S KCNQ1 mutation.0.2800004392009KCNQ1112583453GA,C,T
rs120074184193487853784KCNQ1umls:C0023976BeFreeG314S, co-expressed with WT KCNQ1 and KCNE1, suppressed I(ks) currents in a dominant-negative manner, which is consistent with long QT syndrome in the members of the Chinese family carrying G314S KCNQ1 mutation.0.4165108372009KCNQ1112583453GA,C,T
rs120074189199591323784KCNQ1umls:C0023976BeFreeTrafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.0.4165108372009KCNQ1112778003CT
rs120074189199591323757KCNH2umls:C0023976BeFreeThe trafficking-deficient LQTS mutation KCNQ1-T587M fails to show the chaperoning function that enhances KCNH2 membrane localization with KCNQ1-WT.0.3884828042009KCNQ1112778003CT
rs120074190167542613784KCNQ1umls:C0023976BeFreeA total of six compound heterozygotes were identified who had the HERG R176W mutation in combination with a previously reported LQTS mutation (KCNQ1 G589D or IVS7-2A>G).0.4165108372006KCNQ1112778009GA
rs120074192125222513784KCNQ1umls:C0023976BeFreeFunctional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome.0.4165108372003KCNQ1112527959AG
rs120074192125222513753KCNE1umls:C0023976BeFreeFunctional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome.0.2800004392003KCNQ1112527959AG
rs121912507228763263757KCNH2umls:C0023976BeFreeIsoform-specific dominant-negative effects associated with hERG1 G628S mutation in long QT syndrome.0.3884828042012KCNH27150951511CT,G
rs121912508213768403757KCNH2umls:C0023976BeFreeThe R582C mutation is one of many Long-QT Syndrome type 2 (LQT2)-causing mutations localized to the human ether-a-go-go related gene (hERG) channel's S5-P linker subdomain, yet its specific mechanism of dysfunction has not been examined.0.3884828042011KCNH27150951649GA
rs121912511123547683757KCNH2umls:C0023976BeFreeA novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.0.3884828042002KCNH27150974825TG
rs121912512NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150950311CT
rs121912997NA1832DSPumls:C0023976CLINVARNA0.12NADSP67579989CT
rs121918602NA6262RYR2umls:C0023976CLINVARNA0.126905599NARYR21237454396TC
rs12720452180710696331SCN5Aumls:C0023976BeFreeIn contrast, in 6 of 60 women (10%), we identified 5 rare missense variants in SCN5A that either had been associated previously with long-QT syndrome (A572D and G615E), had been reported to alter sodium channel function (F2004L), or had not been reported previously in control populations (A572F and W1205C).0.3349785012008SCN5A338603758CT
rs12720459179843733784KCNQ1umls:C0023976BeFreeThe common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.0.4165108372007KCNQ1112583535CA,G,T
rs12720459250876183784KCNQ1umls:C0023976BeFreeMembers of a South African LQTS-type 1 founder population (181 noncarriers and 168 mutation carriers) carrying the identical-by-descent KCNQ1 p.Ala341Val (A341V) mutation were evaluated for modifying effects of AKAP9 variants on heart rate-corrected QT interval (QTc), cardiac events, and disease severity.0.4165108372015KCNQ1112583535CA,G,T
rs12720459218548323784KCNQ1umls:C0023976BeFreePartial restoration of the long QT syndrome associated KCNQ1 A341V mutant by the KCNE1 β-subunit.0.4165108372011KCNQ1112583535CA,G,T
rs12720459256348363784KCNQ1umls:C0023976BeFreeThis study tested the hypothesis that vagal and sympathetic control, as assessed by spectral analysis of spontaneous beat-to-beat variability of RR and QT intervals from standard 24-h electrocardiogram Holter recordings, could modulate the severity of LQTS type 1 (LQT1) in 46 members of a South-African LQT1 founder population carrying the clinically severe KCNQ1 A341V mutation.0.4165108372014KCNQ1112583535CA,G,T
rs12720459NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112583535CA,G,T
rs137854600151842836331SCN5Aumls:C0023976BeFreeThe surviving infant was found to have a heterozygous mutation in SCN5A (R1623Q), previously reported as a de novo mutation causing neonatal ventricular arrhythmia and LQTS.0.3349785012004SCN5A338551504CT,A
rs137854601184519986331SCN5Aumls:C0023976BeFreeThe E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.0.3349785012008SCN5A338551022CT
rs137854601248714496331SCN5Aumls:C0023976BeFreeHigh prevalence of the SCN5A E1784K mutation in school children with long QT syndrome living on the Okinawa islands.0.3349785012015SCN5A338551022CT
rs137854614169299196331SCN5Aumls:C0023976BeFreeRecently, two novel missense mutations at the same codon in the gene encoding the cardiac Na+ channel (SCN5A) have been identified: Y1795C (causing the LQTS phenotype) and Y1795H (causing the BrS phenotype).0.3349785012006SCN5A338550988TC
rs137854614128143256331SCN5Aumls:C0023976BeFreeInterestingly another LQT-3 mutant (Y1795C) shows no change in flecainide sensitivity, suggesting that although drug effects of SCN5A mutations cross disease boundaries, clinical management with flecainide will be beneficial to patients in a mutation-specific manner.0.3349785012003SCN5A338550988TC
rs137854615169299196331SCN5Aumls:C0023976BeFreeRecently, two novel missense mutations at the same codon in the gene encoding the cardiac Na+ channel (SCN5A) have been identified: Y1795C (causing the LQTS phenotype) and Y1795H (causing the BrS phenotype).0.3349785012006SCN5A338550989AG
rs137854619NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338550917CT
rs138498207NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150950195GA
rs140452381NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112588815CT
rs141423405NA9992KCNE2umls:C0023976CLINVARNA0.272085018NAKCNE2;LOC1053727912134370707CT
rs142511345NA3753KCNE1umls:C0023976CLINVARNA0.280000439NAKCNE12134449261GA
rs143512106NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150948483GA,T
rs144022753NA3759KCNJ2umls:C0023976CLINVARNA0.127719925NAKCNJ21770176238CG,T
rs144917638NA3753KCNE1umls:C0023976CLINVARNA0.280000439NAKCNE12134449606GA
rs145974930NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112768882GA,C
rs148968498NA9992KCNE2umls:C0023976CLINVARNA0.272085018NAKCNE2;LOC1053727912134370558GA
rs149955375NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150947623GA
rs150172393NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112570733CT
rs151344631185806853784KCNQ1umls:C0023976BeFreeA KCNQ1 V205M missense mutation causes a high rate of long QT syndrome in a First Nations community of northern British Columbia: a community-based approach to understanding the impact.0.4165108372008KCNQ1112571333GA
rs151344631238446333784KCNQ1umls:C0023976BeFreeTwo First Nations communities in northern British Columbia are affected disproportionately with LQTS largely due to the V205M mutation in KCNQ1, however, the pathology and phenotypic expression for those V205M homozygous has been unknown.0.4165108372013KCNQ1112571333GA
rs151344631NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112571333GA
rs17215500NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112768881CG,T
rs17215500245526593784KCNQ1umls:C0023976BeFreePhenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1 families.0.4165108372014KCNQ1112768881CG,T
rs1800171NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112583545GA,C
rs1800172167237813784KCNQ1umls:C0023976BeFreeThe KCNQ1 single nucleotide polymorphism (SNP), G643S, is known to be associated with secondary long QT syndrome (LQTS) and to cause a mild reduction in KCNQ1 current.0.4165108372006KCNQ1;KCNQ1-AS1112847899GA
rs1805123188087223757KCNH2umls:C0023976BeFreeFurthermore, in another LQTS family we found that KCNH2 mutation A490T co-segregated with a common SNP K897T in KCNH2.0.3884828042008KCNH27150948446TG,A
rs1805123201815763757KCNH2umls:C0023976BeFreeOur data suggest that a common polymorphism (K897T) can markedly accentuate the loss of function of mildly defective HERG channels, leading to long-QT syndrome-mediated arrhythmias and sudden infant death.0.3884828042010KCNH27150948446TG,A
rs1805128NA3753KCNE1umls:C0023976CLINVARNA0.280000439NAKCNE12134449382CT
rs1805128244993693753KCNE1umls:C0023976BeFreeInstability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil.0.2800004392013KCNE12134449382CT
rs1805128196954593753KCNE1umls:C0023976BeFreeD85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome.0.2800004392009KCNE12134449382CT
rs1805128212446863784KCNQ1umls:C0023976BeFreeThe common KCNE1 D85N potassium channel variant prolongs QT interval by inhibiting IKs (KCNQ1) and IKr (KCNH2) currents and is therefore a suitable candidate for a modifier gene in LQTS.0.4165108372011KCNE12134449382CT
rs1805128229993243753KCNE1umls:C0023976BeFreeScreening of the genotype disclosed the KCNE1 D85N polymorphism, which is known as one of the typical disease-causing gene variants in long-QT syndrome (LQTS).0.2800004392012KCNE12134449382CT
rs1805128212446863757KCNH2umls:C0023976BeFreeThe common KCNE1 D85N potassium channel variant prolongs QT interval by inhibiting IKs (KCNQ1) and IKr (KCNH2) currents and is therefore a suitable candidate for a modifier gene in LQTS.0.3884828042011KCNE12134449382CT
rs1805128212446863753KCNE1umls:C0023976BeFreeKCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?0.2800004392011KCNE12134449382CT
rs184442491NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338603888CA
rs193922365NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572970CA,T
rs199472678211295033784KCNQ1umls:C0023976BeFreeOrigin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation.0.4165108372011KCNQ1;LOC105376521112445430AG
rs199472678200316353784KCNQ1umls:C0023976BeFreeWe identified 80 mutation carriers in 15 index families, segregating the Y111C-KCNQ1 mutation during a national inventory of mutations causing the long-QT syndrome.0.4165108372009KCNQ1;LOC105376521112445430AG
rs199472688201673033784KCNQ1umls:C0023976BeFreePoint mutation tests for previously identified familial LQTS mutations revealed a positive result in both cases: E146K in KCNQ1 and exon 6-4del in KCNH2.0.4165108372010KCNQ1112527977GA
rs199472690102201463784KCNQ1umls:C0023976BeFreeThe sensitivity of the method was 100% when 34 different point mutations were analyzed, including two previously unpublished LQTS-associated mutations (F157C in KVLQT1 and G572R in HERG), as well as eight novel normal variants in HERG and MYH7.0.4165108371999KCNQ1112528011TG
rs199472690102201463757KCNH2umls:C0023976BeFreeThe sensitivity of the method was 100% when 34 different point mutations were analyzed, including two previously unpublished LQTS-associated mutations (F157C in KVLQT1 and G572R in HERG), as well as eight novel normal variants in HERG and MYH7.0.3884828041999KCNQ1112528011TG
rs199472690102201464625MYH7umls:C0023976BeFreeThe sensitivity of the method was 100% when 34 different point mutations were analyzed, including two previously unpublished LQTS-associated mutations (F157C in KVLQT1 and G572R in HERG), as well as eight novel normal variants in HERG and MYH7.0.0002714421999KCNQ1112528011TG
rs199472709NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572021GA
rs199472713NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572056CA,T
rs199472715108742773784KCNQ1umls:C0023976BeFreeA novel mutation in KVLQT1, L122P, found in a family with autosomal dominant long QT syndrome.0.4165108372000KCNQ1112572078TA,C
rs199472716127105263784KCNQ1umls:C0023976BeFreeBiophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.0.4165108372003KCNQ1112572081TC
rs199472729191673563784KCNQ1umls:C0023976BeFreeWe previously identified a missense mutation F275S located within the S5 transmembrane domain of the KCNQ1 ion channel in a Chinese family with long QT syndrome.0.4165108372009KCNQ1112572889TC
rs199472730NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572895CG,T
rs199472730212418003784KCNQ1umls:C0023976BeFreeBiophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.0.4165108372011KCNQ1112572895CG,T
rs199472737NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572942CT
rs199472749209815423784KCNQ1umls:C0023976BeFreeThree generations of hereditary long-QT syndrome with complete penetrance caused by the p.G316E KCNQ1 mutation.0.4165108372011KCNQ1112583460GA,T
rs199472755NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112583478CA,G,T
rs199472771NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112587581GT
rs199472776235715863784KCNQ1umls:C0023976BeFreeBoth KV7.1-A283T (16-week male) and KV7.1-R397W (16-week female) mutations were associated with marked KV7.1 loss-of-function consistent with in utero LQTS type 1, whereas the HERG1b-R25W mutation (33.2-week male) exhibited a loss of function consistent with in utero LQTS type 2.0.4165108372013KCNQ1112587630CG,T
rs199472776NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112587630CG,T
rs199472792NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112768905AC,G
rs199472804NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112776997CA,T
rs199472830246069953757KCNH2umls:C0023976BeFreeMutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.0.3884828042014KCNH27150974931GT
rs199472862150435093757KCNH2umls:C0023976BeFreeProbucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.0.3884828042004KCNH27150959673AG,C
rs199472862160293853757KCNH2umls:C0023976BeFreeClinical, genetic, and electrophysiologic characteristics of a new PAS-domain HERG mutation (M124R) causing Long QT syndrome.0.3884828042005KCNH27150959673AG,C
rs199472864NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150959622GA
rs199472884NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150958059CG,A
rs199472885NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150957485GA
rs199472904192152403757KCNH2umls:C0023976BeFreeHERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.0.3884828042009KCNH27150952595AG
rs199472924107447923757KCNH2umls:C0023976BeFreeThe distinct HERG missense mutation L564P causes long QT syndrome in one French Canadian family.0.3884828042000KCNH27150951702AG
rs199472934NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150951603TC
rs199472942NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150951562AG,C
rs199472946NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150951546TC
rs199472968120623633757KCNH2umls:C0023976BeFreeCharacterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.0.3884828042002KCNH27150951484CT
rs199472988NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150950362GA
rs199473025NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150947347GA
rs199473028NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150946983GA
rs199473084NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338609803CT
rs199473133126737996331SCN5Aumls:C0023976BeFreeA novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.0.3349785012003SCN5A338603747GA
rs199473133NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338603747GA
rs199473136NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338599026CT,G
rs199473145NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338597925CT
rs199473147NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338597889GA
rs199473192NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338579425GA
rs199473203180710696331SCN5Aumls:C0023976BeFreeIn contrast, in 6 of 60 women (10%), we identified 5 rare missense variants in SCN5A that either had been associated previously with long-QT syndrome (A572D and G615E), had been reported to alter sodium channel function (F2004L), or had not been reported previously in control populations (A572F and W1205C).0.3349785012008SCN5A338575345CA
rs199473293NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338551373CT,G
rs199473311126952866331SCN5Aumls:C0023976BeFreeAn example presented here, the SCN5A LQTS mutant I1768V, does not act to increase Isus (<0.1% of peak) compared with wild-type (WT) channels.0.3349785012003SCN5A338551070TC
rs199473315245990446331SCN5Aumls:C0023976BeFreeFlecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.0.3349785012015SCN5A338551015AT
rs199473321106271396331SCN5Aumls:C0023976BeFreeIdentification of a new SCN5A mutation, D1840G, associated with the long QT syndrome. Mutations in brief no. 153. Online.0.3349785011998SCN5A338550856TC
rs199473348NA3753KCNE1umls:C0023976CLINVARNA0.280000439NAKCNE12134449612GT,A
rs199473354144998623753KCNE1umls:C0023976BeFreeA novel missense mutation, G to A at position 154 in the KCNE1 gene was identified in a Chinese Long QT syndrome family, which leads to an amino acid substitution of arginine (R) for glycine (G) at position 52 (G52R-KCNE1).0.2800004392003KCNE12134449481CT
rs199473362NA3753KCNE1umls:C0023976CLINVARNA0.280000439NAKCNE12134449343GT,A
rs199473365NA9992KCNE2umls:C0023976CLINVARNA0.272085018NAKCNE2;LOC1053727912134370708GA
rs199473394NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112570685GA
rs199473405219520063784KCNQ1umls:C0023976BeFreeArrhythmia formation in subclinical (silent) long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example.0.4165108372012KCNQ1112585249AG
rs199473411NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112585275CT
rs199473432NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150948476CT
rs199473438NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150947813GC,A
rs199473454126536813784KCNQ1umls:C0023976BeFreeClinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome.0.4165108372003KCNQ1112570729TA
rs199473460NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112572862TC
rs199473460198179253784KCNQ1umls:C0023976BeFreeGenetic testing in this LQTS population suggests a common KCNQ1 Leu266Pro founder effect, with the descendants clustering in our geographical region even though no common relative has been identified.0.4165108372010KCNQ1112572862TC
rs199473466167542613784KCNQ1umls:C0023976BeFreeA total of six compound heterozygotes were identified who had the HERG R176W mutation in combination with a previously reported LQTS mutation (KCNQ1 G589D or IVS7-2A>G).0.4165108372006KCNQ1112572975TC
rs199473471NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112585212GA,C
rs19947347917482572805CALM2umls:C0023976BeFreeWe identified the missense mutation M520R in the calmodulin binding domain of the Kv7.1 channel from a German family with long QT-syndrome.0.0010857672007KCNQ1112768888TG
rs19947347917482572808CALM3umls:C0023976BeFreeWe identified the missense mutation M520R in the calmodulin binding domain of the Kv7.1 channel from a German family with long QT-syndrome.0.0010857672007KCNQ1112768888TG
rs199473479174825723784KCNQ1umls:C0023976BeFreeWe identified the missense mutation M520R in the calmodulin binding domain of the Kv7.1 channel from a German family with long QT-syndrome.0.4165108372007KCNQ1112768888TG
rs19947347917482572801CALM1umls:C0023976BeFreeWe identified the missense mutation M520R in the calmodulin binding domain of the Kv7.1 channel from a German family with long QT-syndrome.0.0010857672007KCNQ1112768888TG
rs199473506191361693757KCNH2umls:C0023976BeFreeNovel mutation (H402R) in the S1 domain of KCNH2-encoded gene associated with long QT syndrome in a Spanish family.0.3884828042010KCNH27150952777TC
rs199473532NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150950935TC
rs199473572NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338604863CT
rs199473603172108416331SCN5Aumls:C0023976BeFreeFive variants (S216L, T1304M, F1486L, F2004L, and P2006A) exhibited significantly increased persistent sodium currents (range, 0.5% to 1.7% of peak current) typical of SCN5A mutations associated with long-QT syndrome.0.3349785012007SCN5A338562467GA
rs199473603NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338562467GA
rs199473604193027886331SCN5Aumls:C0023976BeFreeBiophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome.0.3349785012009SCN5A338560394GT
rs199473615172108416331SCN5Aumls:C0023976BeFreeFive variants (S216L, T1304M, F1486L, F2004L, and P2006A) exhibited significantly increased persistent sodium currents (range, 0.5% to 1.7% of peak current) typical of SCN5A mutations associated with long-QT syndrome.0.3349785012007SCN5A338555742AG
rs199473618NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338554498CT,A
rs1994736312399855279727LIN28Aumls:C0023976BeFreeDermal fibroblasts obtained from a patient with LQT3 harboring a SCN5A mutation (c.5287G>A; p.V1763M) were reprogrammed to hiPSCs via repeated transfection of mRNA encoding OCT-4, SOX-2, KLF-4, C-MYC and LIN-28.0.0002714422013SCN5A338551085CT
rs199473631239985525460POU5F1umls:C0023976BeFreeDermal fibroblasts obtained from a patient with LQT3 harboring a SCN5A mutation (c.5287G>A; p.V1763M) were reprogrammed to hiPSCs via repeated transfection of mRNA encoding OCT-4, SOX-2, KLF-4, C-MYC and LIN-28.0.0002714422013SCN5A338551085CT
rs199473631239985524609MYCumls:C0023976BeFreeDermal fibroblasts obtained from a patient with LQT3 harboring a SCN5A mutation (c.5287G>A; p.V1763M) were reprogrammed to hiPSCs via repeated transfection of mRNA encoding OCT-4, SOX-2, KLF-4, C-MYC and LIN-28.0.0002714422013SCN5A338551085CT
rs199473634NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338551036GA
rs199473648NA9992KCNE2umls:C0023976CLINVARNA0.272085018NAKCNE2;LOC1053727912134370507CT
rs199830292238726923762KCNJ5umls:C0023976BeFreeThe phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).0.0005428842014KCNJ511128916630GC
rs201002736172108416331SCN5Aumls:C0023976BeFreeFive variants (S216L, T1304M, F1486L, F2004L, and P2006A) exhibited significantly increased persistent sodium currents (range, 0.5% to 1.7% of peak current) typical of SCN5A mutations associated with long-QT syndrome.0.3349785012007SCN5A338614031GA,T
rs26760727626309258801CALM1umls:C0023976BeFreeHere, we investigated the effect of CaM mutations causing CPVT (N53I), long QT syndrome (D95V and D129G), or both (CaM N97S) on RyR2-mediated Ca(2+) release.0.0010857672016CALM11490401385AT
rs26760727726309258801CALM1umls:C0023976BeFreeHere, we investigated the effect of CaM mutations causing CPVT (N53I), long QT syndrome (D95V and D129G), or both (CaM N97S) on RyR2-mediated Ca(2+) release.0.0010857672016CALM11490404386AG
rs28928905188087223757KCNH2umls:C0023976BeFreeFurthermore, in another LQTS family we found that KCNH2 mutation A490T co-segregated with a common SNP K897T in KCNH2.0.3884828042008KCNH27150952514CT,G
rs28928905111700803757KCNH2umls:C0023976BeFreeWe report a case of a novel HERG mutation (A490T) that caused a bradycardia-associated form of long QT syndrome.0.3884828042001KCNH27150952514CT,G
rs28937317197620976331SCN5Aumls:C0023976BeFreeOur findings revealed for the first time that the LQTS mutation N1325S in SCN5A causes cardiac fibrosis and contractile dysfunction in mice, possibly through cellular mechanisms involving aberrant cardiomyocyte apoptosis.0.3349785012011SCN5A338560418TC
rs36210422167542613757KCNH2umls:C0023976BeFreeThe HERG R176W mutation represents a population-prevalent mutation predisposing to LQTS.0.3884828042006KCNH27150958449GA
rs36210422NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150958449GA
rs36210422167542613784KCNQ1umls:C0023976BeFreeA total of six compound heterozygotes were identified who had the HERG R176W mutation in combination with a previously reported LQTS mutation (KCNQ1 G589D or IVS7-2A>G).0.4165108372006KCNH27150958449GA
rs36210423180710696331SCN5Aumls:C0023976BeFreeIn contrast, in 6 of 60 women (10%), we identified 5 rare missense variants in SCN5A that either had been associated previously with long-QT syndrome (A572D and G615E), had been reported to alter sodium channel function (F2004L), or had not been reported previously in control populations (A572F and W1205C).0.3349785012008SCN5A338603887GT,C,A
rs377095107NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150947341GA
rs397508070NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112583546GA
rs397508097NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112768917CT
rs397508119126536813784KCNQ1umls:C0023976BeFreeClinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome.0.4165108372003KCNQ1112570727TC
rs41261344226824276331SCN5Aumls:C0023976BeFreeIt was reported that the R1193Q polymorphism in the SCN5A gene destabilizes channel inactivation and may be a risk factor for Brugada and long QT syndrome.0.3349785012012SCN5A338575385CT
rs41311117180710696331SCN5Aumls:C0023976BeFreeIn contrast, in 6 of 60 women (10%), we identified 5 rare missense variants in SCN5A that either had been associated previously with long-QT syndrome (A572D and G615E), had been reported to alter sodium channel function (F2004L), or had not been reported previously in control populations (A572F and W1205C).0.3349785012008SCN5A338550362AC,G,T
rs41311117172108416331SCN5Aumls:C0023976BeFreeFive variants (S216L, T1304M, F1486L, F2004L, and P2006A) exhibited significantly increased persistent sodium currents (range, 0.5% to 1.7% of peak current) typical of SCN5A mutations associated with long-QT syndrome.0.3349785012007SCN5A338550362AC,G,T
rs45454496NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113373381GA
rs45465995NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338550683GA
rs45475899NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338585981CT
rs45488304126737996331SCN5Aumls:C0023976BeFreeA novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.0.3349785012003SCN5A338603750GA
rs45489199172108416331SCN5Aumls:C0023976BeFreeFive variants (S216L, T1304M, F1486L, F2004L, and P2006A) exhibited significantly increased persistent sodium currents (range, 0.5% to 1.7% of peak current) typical of SCN5A mutations associated with long-QT syndrome.0.3349785012007SCN5A338550356GC
rs45570339NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113363442CG
rs56157422NA6640SNTA1umls:C0023976CLINVARNA0.12554839NASNTA12033412714GA,C
rs66785829NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113365051TA
rs72544141NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113348277AG
rs72546668NA859CAV3umls:C0023976CLINVARNA0.121628651NACAV3;SSUH238745644CA,T
rs72549410NA6331SCN5Aumls:C0023976CLINVARNA0.334978501NASCN5A338606058CT
rs72552293NA23171GPD1Lumls:C0023976CLINVARNA0.12NAGPD1L332140231AG
rs74315447236317279992KCNE2umls:C0023976BeFreeAn LQTS registry search identified a 55-year male with M54T MiRP1 mutation, history of sinus bradycardia (39-56 bpm), and prolonged QTc.0.2720850182013KCNE2;LOC1053727912134370639TC
rs74315449NA9992KCNE2umls:C0023976CLINVARNA0.272085018NAKCNE2;LOC1053727912134370557CT
rs755287627NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113353494AG
rs786204101NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150947670-G
rs786205420NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113293537CT
rs786205426NA6640SNTA1umls:C0023976CLINVARNA0.12554839NASNTA12033408527GA
rs79299226163013576331SCN5Aumls:C0023976BeFreeAlthough L1825P generates late sodium current typical of SCN5A-linked long-QT syndrome (LQT3) in vitro, the patient reported had a normal QT interval before administration of the drug.0.3349785012005SCN5A338550898AG
rs794728721NA6262RYR2umls:C0023976CLINVARNA0.126905599NARYR21237445489GA
rs794728783NA6262RYR2umls:C0023976CLINVARNA0.126905599NARYR21237783984CT
rs796052166NA3784KCNQ1umls:C0023976CLINVARNA0.416510837NAKCNQ1112571405TG
rs796052195NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150951544AG
rs796052196NA3757KCNH2umls:C0023976CLINVARNA0.388482804NAKCNH27150974709AT
rs796052197NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113354767TC
rs796052198NA287ANK2umls:C0023976CLINVARNA0.129358507NAANK24113356741TC
rs796052199NA10142AKAP9umls:C0023976CLINVARNA0.120542884NAAKAP9792002212TA
rs796052200NA10142AKAP9umls:C0023976CLINVARNA0.120542884NAAKAP9792045186TA
rs79654911NA3753KCNE1umls:C0023976CLINVARNA0.280000439NAKCNE12134449435CT
rs79891110NA775CACNA1Cumls:C0023976CLINVARNA0.121628651NACACNA1C122504944GA
rs9333649102201463757KCNH2umls:C0023976BeFreeThe sensitivity of the method was 100% when 34 different point mutations were analyzed, including two previously unpublished LQTS-associated mutations (F157C in KVLQT1 and G572R in HERG), as well as eight novel normal variants in HERG and MYH7.0.3884828041999KCNH27150951679CT,G,A
rs9333649102201464625MYH7umls:C0023976BeFreeThe sensitivity of the method was 100% when 34 different point mutations were analyzed, including two previously unpublished LQTS-associated mutations (F157C in KVLQT1 and G572R in HERG), as well as eight novel normal variants in HERG and MYH7.0.0002714421999KCNH27150951679CT,G,A
rs9333649107356333757KCNH2umls:C0023976BeFreeLong QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2.0.3884828042000KCNH27150951679CT,G,A
rs9333649102201463784KCNQ1umls:C0023976BeFreeThe sensitivity of the method was 100% when 34 different point mutations were analyzed, including two previously unpublished LQTS-associated mutations (F157C in KVLQT1 and G572R in HERG), as well as eight novel normal variants in HERG and MYH7.0.4165108371999KCNH27150951679CT,G,A
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 329
Disease long qt syndrome
Case(Waiting for update.)